Goertz, Lukas http://orcid.org/0000-0002-2620-7611
Zopfs, David
Kottlors, Jonathan
Borggrefe, Jan
Pennig, Lenhard
Schlamann, Marc
Kabbasch, Christoph
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 3 January 2024
Accepted: 5 May 2024
First Online: 30 May 2024
Declarations
:
: TL previously served as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA), CERUS Endovascular (Fremont, CA, USA), Phenox (Bochum, Germany), Stryker (Kalamazoo, MI, USA), and Medtronic (Dublin, Ireland). FD serves as consultant/ proctor for MicroVention Inc./Sequent Medical, Balt (Irvine, CA, USA), Cerenovus/Johnson&Johnson (Irvine, CA, USA); received speakers honoraria from Cerenovus/ Johnson&Johnson, Acandis (Pforzheim, Germany), Asahi (Tokyo, Japan), Q`Apel (Fremont, CA, USA), Penumbra (Alameda, CA, USA), Medtronic, Stryker; received scientific grants from Cerenovus/ Johnson&Johnson. CK serves as consultant for Acandis GmbH and as proctor for MicroVention Inc./Sequent Medical. DZ is on the speaker’s bureau of Philips (Amsterdam, the Netherlands) and lecturer for Amboss GmbH (Cologne, Germany). The other authors declare that they have no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.